Best supportive care for the anaemia of myelodysplasia: inclusion of recombinant erythropoietin therapy?-Reference-Cited by-同舟云学术

Best supportive care for the anaemia of myelodysplasia: inclusion of recombinant erythropoietin therapy?

Published:2001-01 Issue:1 Volume:25 Page:19-21
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Bowen David T,Hellstrom-Lindberg Eva

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference12 articles.

1. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

2. Anonymous. A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes. Italian Cooperative Study Group for rHuEpo in Myelodysplastic Syndromes, Br J Haematol 103 (1998), 1070.

3. Efficacy of erythropoietin in the myelodysplastic syndromes: a meta-analysis of 205 patients from 17 studies;Hellstrom-Lindberg;Br. J. Haematol.,1995

4. Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model;Hellstrom-Lindberg;Br. J. Haematol.,1997

5. Erythropoietin plus granulocyte colony-stimulating factor in the treatment of myelodysplastic syndromes. Identification of a subgroup of responders;Remacha;Haematologica,1999

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discontinuation of the renin–angiotensin system inhibitors improves erythropoiesis in patients with lower-risk myelodysplastic syndromes;Therapeutic Advances in Hematology;2021-01

2. Epoetin alfa for the treatment of myelodysplastic syndrome-related anemia: A review of clinical data, clinical guidelines, and treatment protocols;Leukemia Research;2019-06

3. A comparative study of deferasirox and deferiprone in the treatment of iron overload in patients with myelodysplastic syndromes;Leukemia Research;2013-12

4. Efficacy And Safety Of Administration Of Oral Iron Chelator Deferiprone In Patients With Early Myelodysplastic Syndrome;Hemoglobin;2011-05-20

5. Supportive Therapie bei Myelodysplastischem Syndrom (MDS). Unverzichtbare Säule im multimodalen Behandlungskonzept;Pharmazie in unserer Zeit;2010-04-27